In 2025, the global cancer immunotherapy market was valued at over 150 billion U.S. dollars. The market is likely to increase by two-fold to over 327 billion U.S. dollars by 2035.Â
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Nova One Advisor. (June 2, 2026). Global cancer immunotherapy market from 2025 to 2035 (in billion U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 28, 2026, from /statistics/670674/cancer-immunotherapy-sales-worldwide/
Nova One Advisor. "Global cancer immunotherapy market from 2025 to 2035 (in billion U.S. dollars)." Chart. June 2, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 28, 2026. /statistics/670674/cancer-immunotherapy-sales-worldwide/
Nova One Advisor. (2026). Global cancer immunotherapy market from 2025 to 2035 (in billion U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 28, 2026. /statistics/670674/cancer-immunotherapy-sales-worldwide/
Nova One Advisor. "Global Cancer Immunotherapy Market from 2025 to 2035 (in Billion U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 2 Jun 2026, /statistics/670674/cancer-immunotherapy-sales-worldwide/
Nova One Advisor, Global cancer immunotherapy market from 2025 to 2035 (in billion U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/670674/cancer-immunotherapy-sales-worldwide/ (last visited July 28, 2026)
Global cancer immunotherapy market from 2025 to 2035 (in billion U.S. dollars) [Graph], Nova One Advisor, June 2, 2026. [Online]. Available: /statistics/670674/cancer-immunotherapy-sales-worldwide/
